Live Breaking News & Updates on Cecilia Jones

Stay updated with breaking news from Cecilia jones. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript February 15, 2024 Agios Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. And welcome to the Agios Fourth Quarter 2023 Earnings Conference Call. At this time, all […] ....

Brian Goff , Cecilia Jones , Tsveta Milanova , Brands With The Least Chemicals , Sickle Cell Disease , Agios Pharmaceuticals , Brian Goff , Chris Taylor , Cecilia Jones , Thalassemia Patients ,

Agios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Down After Earnings Miss

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) gapped down prior to trading on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $25.90, but opened at $24.93. Agios Pharmaceuticals shares last traded at $25.44, with a volume of 66,412 shares. The biopharmaceutical company reported ($1.72) earnings per […] ....

Brian Goff , Cecilia Jones , Jpmorgan Chase Co , Dimensional Fund Advisors , News Ratings For Agios Pharmaceuticals Daily , Goldman Sachs Group , Agios Pharmaceuticals Inc , Royal Bank , Cantor Fitzgerald , Norges Bank , Agios Pharmaceuticals Price Performance , Asset Management Americas Inc , Securities Exchange Commission , Institutional Trading Of Agios Pharmaceuticals , First Trust Advisors , Agios Pharmaceuticals , Get Free Report , Exchange Commission , Fund Advisors , Management Americas , Trust Advisors , Agios Pharmaceuticals Daily , Nasdaq Agio ,

Agios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Down After Earnings Miss

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) gapped down prior to trading on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $25.90, but opened at $24.93. Agios Pharmaceuticals shares last traded at $25.44, with a volume of 66,412 shares. The biopharmaceutical company reported ($1.72) earnings per […] ....

Brian Goff , Cecilia Jones , Cantor Fitzgerald , Jpmorgan Chase Co , Dimensional Fund Advisors , News Ratings For Agios Pharmaceuticals Daily , Goldman Sachs Group , Royal Bank , Agios Pharmaceuticals Inc , Securities Exchange Commission , Agios Pharmaceuticals , First Trust Advisors , Institutional Trading Of Agios Pharmaceuticals , Norges Bank , Agios Pharmaceuticals Price Performance , Asset Management Americas Inc , Get Free Report , Exchange Commission , Fund Advisors , Management Americas , Trust Advisors , Agios Pharmaceuticals Daily , Nasdaq Agio ,